- ►nih.gov K Rajamani, PG Colman, LP Li, JD Best, M … - The Lancet, 2009 - Elsevier In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study,
9795 patients aged 50–75 years with type 2 diabetes were randomly assigned by
computer-generated randomisation sequence to receive fenofibrate 200 mg per ... Cited by 4 - Related articles - All 41 versions
WH Smiley, BV Khan, LS Sperling - Current Treatment Options in Cardiovascular Medicine, 2009 - Springer The 3-hydroxy-3-methylglutaryl coenzyme A reduc- tase inhibitors (statins) have
a compelling track record. Large-scale clinical trials consistently have
demonstrated their effectiveness in reducing car- diovascular events and ... Related articles - All 2 versions
MM Vasudevan, CM Ballantyne - Endocrine Practice - AACE Page 1. 1 Advances in Lipid Testing and Management in Diabetics Madhuri
M. Vasudevan, MD, MPH Christie M. Ballantyne, MD Center for ... Related articles - All 2 versions
SFE Praet, LJC van Loon - Acta Diabetologica - Springer Abstract Structured exercise is considered an important cornerstone to achieve
good glycemic control and improve cardiovascular risk profile in Type 2
diabetes. Current clinical guidelines acknowledge the therapeutic strength ... Related articles - All 4 versions
AS Wierzbicki - Current Opinion in Cardiology, 2009 - journals.lww.com Recent findings: Endpoint studies have been conducted with fibrates in coronary
heart disease (CHD) since 1971 and initial results were contradictory. Fibrates
later showed benefits in patients with low HDL-C and low LDL-C. The ... Related articles - All 4 versions
C Fiévet, B Staels - Current Opinion in Lipidology, 2009 - pdfs.journals.lww.com Introduction An elevated LDL cholesterol (LDL-C) level is a major risk factor
for cardiovascular disease (CVD), and several randomized clinical trials have
shown that lowering LDL-C levels with statins results in a substantial ... Related articles - All 4 versions
MM Vasudevan, CM Ballantyne - Endocrine Practice, 2009 - AACE Submitted for publication July 7, 2009 Accepted for publication July 7, 2009
From the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart
and Vascular Center and Section of Atherosclerosis and Vascular Medicine, ...